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Immunization clinical decision support (CDS), more commonly referred to as evaluation and forecasting, 
is an automated process that determines the recommended immunizations needed for a patient 
and delivers those recommendations to the healthcare provider. Health Information Systems (HIS), 
which include Immunization Information Systems (IIS), Electronic Health Records (EHRs), and Health 
Information Exchanges (HIEs), create CDS tools based on schedules and guidelines developed by the 
Advisory Committee on Immunization Practices (ACIP), a federal advisory committee responsible for 
providing expert external advice and guidance on the use of vaccines and related agents for control 
of vaccine-preventable disease in the United States. ACIP recommendations include age for vaccine 
administration, number of doses, dosing interval, and precautions and contraindications.
After ACIP recommendations are published, technical and clinical subject matter experts (SMEs) work 
to interpret and integrate them into their CDS engines. New ACIP schedule changes are currently 
communicated only through scientific language, in publications like the Morbidity and Mortality 
Weekly Report (MMWR) and the Epidemiology and Prevention of Vaccine-Preventable Diseases (“The 
Pink Book”). The translation of that scientific language into technical logic that can be processed within 
CDS engines is a time-consuming and complex process that happens mostly independently within the 
different HIS. Because interpretation of clinically-written ACIP recommendations can be challenging, CDS 
engine outputs often vary and do not always match the expectations of clinical SMEs.
The Clinical Decision Support for Immunization (CDSi) Project
In an effort to harmonize the outcomes of existing CDS tools, the Immunization Information System 
Support Branch (IISSB) at the Centers for Disease Control and Prevention (CDC) funded a project to 
develop a logic specification for the childhood and adolescent immunization schedules. The goals of the 
project included:
yy Increasing the accuracy and consistency of immunization evaluation and forecasting
yy Improving the ease of developing and maintaining immunization CDS products
yy Improving the process of updating CDS logic with new and/or changed ACIP recommendations
Improving CDS engines ultimately ensures that patients receive proper immunizations. i.e. “the right 
immunization at the right time”
As part of this project, an expert panel was formed in April 2011, consisting of SMEs and expert reviewers 
from:
yy CDC Public Health Informatics and Technology Program Office (PHITPO)
yy American Immunization Registry Association (AIRA)
yy Indian Health Service (IHS)
yy Electronic Health Record (EHR) vendors
yy HIS programs and vendors
yy Academic institutions
This panel was divided into the following three workgroups which met regularly to develop resources in 
support of the project’s goals:
yy Logic Specification Panel (LSP)– Developed the Logic Specification for ACIP Recommendations, 
which captures ACIP recommendations in an unambiguous manner and improves both the uniform 
representation of vaccine decision guidelines, as well as the ability to automate vaccine evaluation 
and forecasting.
yy Validation and Testing Panel (VTP)– Created the CDSi Testing Methodology to extensively test 
the accuracy of CDS logic representation within CDS engines.
yy Process, Communication and Sustainability Panel (PCSP)– Produced a Sustainability Plan to 
ensure the long-term viability of the CDSi resources.
Scope
The vaccine groups in scope are those routinely recommended by ACIP for healthy children from birth 
through 18 years, including:
Vaccine Groups
yy Diphtheria, Tetanus, 
and Pertussis/Tetanus-
diphtheria (DTaP, Tdap, Td)
yy Haemophilus influenzae 
type B (Hib)
yy Meningococcal conjugate 
vaccine (MCV)
yy Polio
yy Hepatitis A yy Human papillomavirus 
(HPV)
yy Measles, Mumps, Rubella 
(MMR)
yy Rotavirus
yy Hepatitis B yy Influenza (Flu) yy Pneumococcal conjugate 
vaccine (PCV)
yy Varicella
Additional items in scope include:
Item Notes
yy Current ACIP recommendations with clarifications ACIP recommendations exist in a few different formats. 
An appendix in the Logic Specification lists these. 
yy Compromised/sub-potent/expired doses
yy Vaccine recalls
yy Wrong vaccine formulations
yy Underlying conditions related to 
contraindications listed in the General 
Recommendations
yy The 4-day grace period
Items currently out of scope include:
Item Notes
yy Non-ACIP published rules
State law variations from ACIP
Local school schedules
Rules published by other organizations
Rules published in other countries
While not addressed specifically, the Logic Specification 
was developed to accommodate these different rules. 
Supporting data in the specification can be adjusted by 
implementers to cover these variations from the ACIP 
recommendations.
yy Adult vaccines
yy Underlying conditions related to precautions and 
special indications
yy High/increased/special risk series (e.g. HIB past 5 
years, MCV HIV series)
yy Immune Globulin (IG)
yy Route and body site of administration
yy Travel vaccines
yy Vaccine shortages
yy Non-FDA approved vaccines (e.g. those used in 
clinical trial)
yy A schedule without a 4-day grace period
These items are currently excluded from scope but are 
candidates for future consideration.
The Logic Specification
The panel developed the Logic Specification for 
ACIP Recommendations, which captures ACIP 
recommendations in an unambiguous manner and 
improves both the uniform representation of vaccine 
decision guidelines as well as the ability to automate vaccine 
evaluation and forecasting. The Logic Specification provides 
a single, authoritative, implementation-neutral foundation 
for development and maintenance of CDS engines.
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Logic Specification Design and Documentation Strategy
The complexity of the problem and the goals of the project influenced the design strategy.  
The guiding principles were:
yy Separate the complex problem into simpler, more focused parts. The data, algorithm, and 
framework that pulls the data and algorithm together each became separate components.
yy Emphasize “universal” functionality applicable across IIS implementations instead of more detailed, 
implementation-specific engineering requirements for local needs and technical environments.
yy Utilize a variety of mechanisms to document the specification, providing a concise, unambiguous, 
computable description of the functionality required. These mechanisms include decision tables, 
business rules, process models, and a domain model.
Logic Specification Components
The Logic Specification consists of the following three components:
Component Description
Supporting Data
Describes, by antigen, various factors and their accompanying 
sets of values to be considered when implementing ACIP 
recommendations.
Logic Definition
Describes the functionality required to evaluate and forecast based 
on a patient’s immunization history and the supporting data.
Processing Model
Describes the structure necessary to pull the details of the logic 
definition, supporting data and patient-related data together.
Testing the Specification
The panel developed a Testing Methodology to validate recommendations delivered by CDS engines. 
Test cases and expected results were created and can be used to validate or test a CDS algorithm 
against the Logic Specification.










gy Test Cases Provide a representative set of scenarios and their expected outcomes as dictated by the Logic Specification.
Testing Document Details the process used to develop the test cases and how to maintain them.
Target Audience
The target audience for the Logic Specification 
for ACIP Recommendations includes 
business and/or technical implementers 
of immunization CDS engines. These 
implementers may support any system with 
an immunization evaluation and forecasting 
engine, including but not limited to IIS.
The Logic Specification was developed to be as 
implementation-neutral as possible to support 
those currently with or without complete evaluation and forecasting engines as they:
yy Refine, extend and/or develop their implementation
yy Clarify their understanding
yy Troubleshoot and/or verify correct implementation
The intended audience of the Testing Methodology is implementers of immunization evaluation 
and forecasting products and services with a sound understanding of immunization evaluation and 
forecasting testing. Both business analysts and software developers will find value in the testing 
components.
Frequently Asked Questions:
How will state and local differences be handled? 
State and local differences can be supported within the Logic Specification through modification 
of the supporting data. The supporting data was separated from the logic definition to simplify the 
maintenance required when new ACIP recommendations are released. Although the definition of which 
attributes can be described will be relatively static, as new recommendations are made, changes in at 
least some of the values are highly likely. If supporting data is ultimately implemented as some form of 
data store or in a database, changes to the Logic Specification would require minimal, if any, updates 
to the coded system. Separating the supporting data makes it easier to support local differences, state 
laws, etc., with minimal impact on the implemented logic or code.
How will I get support? 
Users of the CDSi resources will obtain support via email to nipinfo@cdc.gov. 
What will happen when ACIP makes recommendation changes? 
Each time ACIP updates its recommendations, a team designated to maintain the Logic Specification 
will update the resource accordingly. Subsequently, communications will be disseminated to the 
community to make them aware of the changes.
The Logic Specification can be found on the IISSB web site at:  
http://www.cdc.gov/vaccines/programs/iis/interop-proj/cds.html 
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